Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Debt

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Debt History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Debt ₹991 Cr₹4,348 Cr₹3,670 Cr₹4,687 Cr₹4,869 Cr

What is the latest Total Debt ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Debt ratio of GLENMARK PHARMACEUTICALS is ₹991 Cr based on Mar2024 Consolidated results.
Year Total Debt
Mar2024₹991 Cr
Mar2023₹4,348 Cr
Mar2022₹3,670 Cr
Mar2021₹4,687 Cr
Mar2020₹4,869 Cr

How is Total Debt of GLENMARK PHARMACEUTICALS Trending?

Years Total Debt % Change
Mar2024 ₹991 Cr
-77.22
Mar2023 ₹4,348 Cr
18.46
Mar2022 ₹3,670 Cr
-21.70
Mar2021 ₹4,687 Cr
-3.72
Mar2020 ₹4,869 Cr -

Compare Total Debt of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹39,503.8 Cr -6.8% -12% 57.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,303.0 Cr -5.1% -9.4% 29.2% Stock Analytics
DIVIS LABORATORIES ₹143,389.0 Cr -7.3% -10.9% 53% Stock Analytics
CIPLA ₹114,645.0 Cr -1.4% -6.7% -1.5% Stock Analytics
DR REDDYS LABORATORIES ₹98,449.5 Cr -9% -14.4% 1.4% Stock Analytics
ZYDUS LIFESCIENCES ₹91,587.4 Cr -7% -5% 22.6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-6.8%

-12%

57.4%

SENSEX

0.1%

-3.6%

7.9%


You may also like the below Video Courses